Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Research ArticleBrain

Diffusion-weighted Imaging of Metastatic Brain Tumors: Comparison with Histologic Type and Tumor Cellularity

Y. Hayashida, T. Hirai, S. Morishita, M. Kitajima, R. Murakami, Y. Korogi, K. Makino, H. Nakamura, I. Ikushima, M. Yamura, M. Kochi, J.-i. Kuratsu and Y. Yamashita
American Journal of Neuroradiology August 2006, 27 (7) 1419-1425;
Y. Hayashida
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Hirai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Morishita
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Kitajima
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Murakami
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y. Korogi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Makino
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Nakamura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I. Ikushima
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Yamura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Kochi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.-i. Kuratsu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y. Yamashita
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 1.

    Comparison of the signal intensity of 26 metastatic brain tumors on diffusion-weighted images. All 6 well differentiated adenocarcinomas (Well diff. AC) were classified as grade −2, −1, or 0. All 3 small-cell carcinomas (Small cell ca.) and 1 large-cell neuroendocrine carcinoma (LCNC) were graded as +2. A malignant melanoma was grade −1; all other tumors were grade 0 or +1. Poorly diff. AC, indicates poorly differentiated adenocarcinomas; Large cell ca., large cell carcinoma; SCC, squamous cell carcinoma; Papillotubular ca., papillotubular carcinoma; Mucoepidermoid ca., mucoepidermoid carcinoma; Mod. diff. AC, moderately differentiated adenocarcinoma. The signal intensity was graded on a point scale: −2 = hypointense relative to the normal-appearing white matter; −1 = isointense relative to the normal-appearing white matter; 0 = isointense relative to the normal-appearing cortical gray matter; +1 = slightly hyperintense relative to the normal-appearing cortical gray matter; and +2 = hyperintense relative to the normal-appearing cortical gray matter.

  • Fig 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 2.

    A 67-year-old man with a well differentiated adenocarcinoma from the lung.

    A, T2-weighted fast spin-echo image shows a parietotemporal lesion (arrow) near the trigone of the left lateral ventricle. It is hypointense relative to the normal-appearing white matter. The CNR of the solid lesion was 12.

    B, On contract-enhanced T1-weighted image, the lesion is enhanced (arrow).

    C, On DWI, the lesion is hypointense relative to the normal-appearing white matter (arrow). It was graded as −2.

    D, On ADC map, the nADC of the lesion was calculated as 1.95.

    E, Photomicrograph of the specimen (hematoxylin-eosin stain; original magnification, 40×) shows a well-differentiated acinar structure. Tumor cellularity was calculated as 0.179.

  • Fig 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 3.

    A 41-year-old man with a poorly differentiated adenocarcinoma from the lung.

    A, T2-weighted fast spin-echo image shows a left parietal subcortical lesion (arrow). It is slightly hyperintense relative to the normal-appearing white matter. The CNR of the solid lesion was 32.

    B, On contract-enhanced T1-weighted image, the lesion is well enhanced (arrow).

    C, On DWI, the lesion is slightly hyperintense relative to the normal-appearing cortical gray matter (arrow). It was graded as +1.

    D, On ADC map, the nADC of the lesion was calculated as 1.45.

    E, Photomicrograph of the specimen (hematoxylin-eosin stain; original magnification, 40×) shows higher cellularity than Fig 2E. Tumor cellularity was calculated as 0.334.

  • Fig 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 4.

    A 69-year-old man with small-cell carcinoma from the lung.

    A, On T2-weighted fast spin-echo image, the solid portion of a right parietal mass lesion (arrow) is hyperintense relative to the normal-appearing white matter. The CNR of the enhancing lesion was 45.

    B, On contract-enhanced T1-weighted image, the peripheral region of the lesion is enhanced (arrow).

    C, On DWI, the lesion is hyperintense relative to the normal-appearing cortical gray matter (arrow). The lesion was graded as +2.

    D, On ADC map, the solid lesion is slightly hyperintense. Its nADC was calculated as 0.57.

    E, Photomicrograph of the specimen (hematoxylin-eosin stain; original magnification, 40×) shows high cellularity. The tumor cellularity was calculated as 0.72.

  • Fig 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 5.

    A 63-year-old man with large cell neuroendocrine carcinoma from the lung.

    A, On T2-weighted fast spin-echo image, the solid portion of left occipital lesion (arrow) is hyperintense relative to the normal-appearing white matter. The CNR of the enhancing lesion was 56.

    B, On contrast-enhanced T1-weighted image, the posterior part of the lesion is enhanced (arrow). There are multiple enhancing areas (arrowheads) in the left frontal lobe indicative of subacute infarction.

    C, On DWI, the solid lesion is hyperintense relative to the normal-appearing cortical gray matter (arrow). The lesion was ranked as grade +2.

    D, On ADC map, the solid lesion is hypointense; its nADC was calculated as 1.04.

    E, Photomicrograph of the specimen (hematoxylin-eosin stain; original magnification, 40×) shows high cellularity. The tumor cellularity was calculated as 0.51.

  • Fig 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 6.

    Comparison of the nADC value and CNR on T2-weighted images of 26 metastatic brain tumors of different histologic types. Most well differentiated adenocarcinomas (Well diff. AC) are distributed at high nADC and low CNR. Of the 3 small-cell carcinomas (Small cell ca.), 2 exhibit nADC values below 1.0. The large-cell neuroendocrine carcinoma (LCNC) manifests low nADC value and high CNR. Poorly differentiated adenocarcinoma (Poorly diff. AC), papillotubular carcinoma (Papillotubular ca.), sarcoma, and malignant melanoma (Melanoma) also exhibit low nADC values. Large cell ca. indicates large cell carcinoma; SCC, squamous cell carcinoma; Mucoepidermoid ca.: mucoepidermoid carcinoma; Mod. diff. AC, moderately differentiated adenocarcinoma.

  • Fig 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 7.

    Comparison of the signal intensity of 13 histologically confirmed brain lesions on diffusion-weighted images. All 4 well differentiated adenocarcinomas (Well diff. AC) were graded as −2 or −1, and 2 poorly differentiated adenocarcinomas (Poorly diff. AC) as +1. One small-cell carcinoma (Small cell ca.) and 1 large-cell neuroendocrine carcinoma (LCNC) were both graded as +2. The other lesions were graded as 0 or +1. The signal intensity was graded on 5-point scale as described in Fig 1. Large cell ca., large cell carcinoma; SCC, squamous cell carcinoma; Papillotubular ca., papillotubular indicates carcinoma; Mucoepidermoid ca., mucoepidermoid carcinoma.

  • Fig 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 8.

    Comparison of the nADC value and CNR on T2-weighted images of 13 histologically confirmed brain lesions. Most well differentiated adenocarcinomas (Well diff. AC) are distributed at high nADC and low CNR. One small-cell carcinoma (Small cell ca.) and 1 large cell neuroendocrine carcinoma (LCNC) were distributed at low nADC and high CNR. Poorly diff. AC indicates poorly differentiated adenocarcinoma; Large cell ca., large cell carcinoma; SCC, squamous cell carcinoma; Mucoepidermoid ca., mucoepidermoid carcinoma; Papillotubular ca., papillotubular carcinoma.

  • Fig 9.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 9.

    Relationship between nADC and tumor cellularity. The nADC value inversely correlated well with tumor cellularity (r = −0.70, P = .0059).

Tables

  • Figures
    • View popup
    Table 1:

    Summary of 26 primary malignant lesions

    Histopathology of Primary LesionNo. of LesionsPrimary Site (No. of Sites)
    Adenocarcinoma13
        Well differentiated6Lung (4), ovary (1), uterus (1)
        Moderately differentiated1Lung (1)
        Poorly differentiated6Lung (6)
    Small-cell carcinoma3Lung (3)
    Large-cell carcinoma2Lung (2)
    Squamous cell carcinoma2Esophagus (2)
    Papillotubular carcinoma2Breast (2)
    LCNC1Lung (1)
    Mucoepidermoid carcinoma1Lung (1)
    Sarcoma1Synovium (1)
    Malignant melanoma1Skin (1)
    • Note:—LCNC indicates large-cell neuroendocrine carcinoma.

    • View popup
    Table 2:

    Summary of 13 operated brain lesions

    Histopathology of Brain LesionNo. of LesionsPrimary site (No. of Sites)
    Adenocarcinoma6
        Well differentiated4Lung (3), ovary (1)
        Poorly differentiated2Lung (2)
    Squamous cell carcinoma2Esophagus (2)
    Small-cell carcinoma1Lung (1)
    Large-cell carcinoma1Lung (1)
    Papillotubular carcinoma1Breast (1)
    LCNC1Lung (1)
    Mucoepidermoid carcinoma1Lung (1)
    • Note:—LCNC indicates large-cell neuroendocrine carcinoma.

PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 27 (7)
American Journal of Neuroradiology
Vol. 27, Issue 7
August 2006
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Diffusion-weighted Imaging of Metastatic Brain Tumors: Comparison with Histologic Type and Tumor Cellularity
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
Y. Hayashida, T. Hirai, S. Morishita, M. Kitajima, R. Murakami, Y. Korogi, K. Makino, H. Nakamura, I. Ikushima, M. Yamura, M. Kochi, J.-i. Kuratsu, Y. Yamashita
Diffusion-weighted Imaging of Metastatic Brain Tumors: Comparison with Histologic Type and Tumor Cellularity
American Journal of Neuroradiology Aug 2006, 27 (7) 1419-1425;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Diffusion-weighted Imaging of Metastatic Brain Tumors: Comparison with Histologic Type and Tumor Cellularity
Y. Hayashida, T. Hirai, S. Morishita, M. Kitajima, R. Murakami, Y. Korogi, K. Makino, H. Nakamura, I. Ikushima, M. Yamura, M. Kochi, J.-i. Kuratsu, Y. Yamashita
American Journal of Neuroradiology Aug 2006, 27 (7) 1419-1425;
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Associations Between ADC Texture Analysis and Tumor Infiltrating Lymphocytes in Brain Metastasis - A Preliminary Study
  • Sequential Apparent Diffusion Coefficient for Assessment of Tumor Progression in Patients with Low-Grade Glioma
  • Diffusion-Weighted Imaging of Brain Metastasis from Lung Cancer: Correlation of MRI Parameters with the Histologic Type and Gene Mutation Status
  • A Multiparametric Model for Mapping Cellularity in Glioblastoma Using Radiographically Localized Biopsies
  • Differentiating Hemangioblastomas from Brain Metastases Using Diffusion-Weighted Imaging and Dynamic Susceptibility Contrast-Enhanced Perfusion-Weighted MR Imaging
  • The efficacy of diffusion weighted imaging and apparent diffusion coefficients mapping for liver metastasis of colonic adenocarcinomas
  • Parametric Response Mapping of Apparent Diffusion Coefficient as an Imaging Biomarker to Distinguish Pseudoprogression from True Tumor Progression in Peptide-Based Vaccine Therapy for Pediatric Diffuse Intrinsic Pontine Glioma
  • "Dazed and diffused": making sense of diffusion abnormalities in neurologic pathologies
  • Correlation of 18F-FDG Uptake with Apparent Diffusion Coefficient Ratio Measured on Standard and High b Value Diffusion MRI in Head and Neck Cancer
  • Differentiation between Glioblastomas, Solitary Brain Metastases, and Primary Cerebral Lymphomas Using Diffusion Tensor and Dynamic Susceptibility Contrast-Enhanced MR Imaging
  • Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance
  • Imaging Immune Response In vivo: Cytolytic Action of Genetically Altered T Cells Directed to Glioblastoma Multiforme
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Predictors of Reperfusion in Patients with Acute Ischemic Stroke
  • Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis
  • Progression of Microstructural Damage in Spinocerebellar Ataxia Type 2: A Longitudinal DTI Study
Show more Brain

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire